Fmr LLC Xeris Biopharma Holdings, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Fmr LLC holds 326,420 shares of XERS stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

326,420

Previous 311,472 4.8%

Holding current value

$2.63 Million

Previous $1.71 Million 10.83%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.95 - $5.16 $59,044 - $77,131	14,948 Added 4.8%	326,420 $1.52 Million
Q1 2025 May 12, 2025	BUY	$3.2 - $5.95 $843,833 - $1.57 Million	263,698 Added 551.97%	311,472 $1.71 Million
Q4 2024 Feb 13, 2025	BUY	$2.78 - $3.73 $73,208 - $98,225	26,334 Added 122.83%	47,774 $161,000
Q3 2024 Nov 13, 2024	BUY	$2.06 - $2.96 $838 - $1,204	407 Added 1.94%	21,440 $61,000
Q2 2024 Aug 13, 2024	BUY	$1.7 - $2.45 $13,404 - $19,318	7,885 Added 59.97%	21,033 $47,000
Q1 2024 May 13, 2024	BUY	$2.04 - $3.22 $1,381 - $2,179	677 Added 5.43%	13,148 $29,000
Q4 2023 Feb 13, 2024	BUY	$1.47 - $2.36 $4,673 - $7,502	3,179 Added 34.21%	12,471 $29,000
Q3 2023 Nov 13, 2023	SELL	$1.8 - $2.69 $93 - $139	-52 Reduced 0.56%	9,292 $17,000
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $422 - $691	232 Added 2.55%	9,344 $24,000
Q1 2023 May 11, 2023	BUY	$1.03 - $1.63 $6,073 - $9,612	5,897 Added 183.42%	9,112 $14,000
Q4 2022 Feb 13, 2023	BUY	$1.14 - $1.65 $323 - $468	284 Added 9.69%	3,215 $4,000
Q3 2022 Nov 10, 2022	BUY	$1.37 - $1.93 $2,855 - $4,022	2,084 Added 246.04%	2,931 $5,000
Q2 2022 Aug 12, 2022	BUY	$1.48 - $2.64 $509 - $908	344 Added 68.39%	847 $1,000
Q1 2022 May 13, 2022	BUY	$2.0 - $2.87 $1,006 - $1,443	503 New	503 $1,000

Others Institutions Holding XERS

# of Institutions

207

Shares Held

89.8M

Call Options Held

81.6K

Put Options Held

57.6K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $1.1B
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account